Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.16% is in line with its 5-year average of 57.40%, near the high end of its 5-year range (45.21%–61.20%).
2.62% above its 12-month average of 56.67%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 55.57%.
GROSS MARGIN
58.16%
GROSS MARGIN AVG TTM
56.67%
GROSS MARGIN AVG 3Y
57.53%
GROSS MARGIN AVG 5Y
57.40%
GROSS MARGIN AVG 10Y
54.28%
GROSS MARGIN AVG 15Y
51.51%
GROSS MARGIN AVG 20Y
50.73%
CURRENT VS TTM AVG
+2.62%
CURRENT VS 3Y AVG
+1.09%
CURRENT VS 5Y AVG
+1.32%
CURRENT VS 10Y AVG
+7.15%
CURRENT VS 15Y AVG
+12.91%
CURRENT VS 20Y AVG
+14.64%
SECTOR MEDIAN · HEALTHCARE
39.94%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
+45.62%
vs the sector median at left
Harvard Bioscience, Inc.
Market Cap
$39.10M
Gross Margin
58.16%
TTM Avg
56.67%
3Y Avg
57.53%
5Y Avg
57.40%
Market Cap
$38.35M
Gross Margin
0.00%
TTM Avg
-93.03%
3Y Avg
-21.51%
5Y Avg
10.85%
Market Cap
$39.91M
Gross Margin
74.29%
TTM Avg
89.45%
3Y Avg
39.47%
5Y Avg
19.73%
Market Cap
$36.80M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
Market Cap
$41.79M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $39.10M | 58.16% | 56.67% | 57.53% | 57.40% |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | 0.00% | -93.03% | -21.51% | 10.85% |
| Nephros, Inc. (NEPH)vs › | $39.90M | 60.31% | 61.36% | 57.30% | 56.95% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.91M | 74.29% | 89.45% | 39.47% | 19.73% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.28M | 0.00% | 0.00% | 0.00% | 15.78% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.80M | 0.00% | 0.00% | 0.00% | 22.09% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precipio, Inc. (PRPO)vs › | $41.92M | 43.69% | 45.94% | 39.54% | 34.01% |
| Elutia Inc (ELUT)vs › | $35.54M | 57.82% | 48.80% | 47.77% | 46.56% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.80M | 39.56% | 49.73% | -33.76% | -21.28% |
Gross Margin
58.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 55.57% |
| 2026-03-31 | 58.99% |
| 2025-12-31 | 59.71% |
| 2025-09-30 | 58.38% |
| 2025-06-30 | 50.71% |
| 2025-03-31 | 55.96% |
| 2024-12-31 | 57.06% |
| 2024-09-30 | 58.10% |
| 2024-06-30 | 57.23% |
| 2024-03-31 | 60.26% |
| 2023-12-31 | 53.06% |
| 2023-09-30 | 58.06% |
| 2023-06-30 | 57.97% |
| 2023-03-31 | 61.20% |
| 2022-12-31 | 55.70% |
| 2022-09-30 | 45.21% |
| 2022-06-30 | 56.96% |
| 2022-03-31 | 56.21% |
| 2021-12-31 | 59.17% |
| 2021-09-30 | 54.98% |
| 2021-06-30 | 56.01% |
| 2021-03-31 | 57.18% |
| 2020-12-31 | 57.15% |
| 2020-09-30 | 56.14% |
| 2020-06-30 | 59.45% |
| 2020-03-31 | 54.61% |
| 2019-12-31 | 55.64% |
| 2019-09-30 | 54.63% |
| 2019-06-30 | 53.93% |
| 2019-03-31 | 57.28% |
| 2018-12-31 | 55.35% |
| 2018-09-30 | 55.24% |
| 2018-06-30 | 48.71% |
| 2018-03-31 | 49.59% |
| 2017-12-31 | 47.96% |
| 2017-09-30 | 46.46% |
| 2017-06-30 | 44.77% |
| 2017-03-31 | 47.60% |
| 2016-12-31 | 45.83% |
| 2016-09-30 | 46.75% |
| 2016-06-30 | 44.67% |
| 2016-03-31 | 48.01% |
| 2015-12-31 | 45.56% |
| 2015-09-30 | 45.57% |
| 2015-06-30 | 43.73% |
| 2015-03-31 | 44.55% |
| 2014-12-31 | 45.66% |
| 2014-09-30 | 44.96% |
| 2014-06-30 | 45.54% |
| 2014-03-31 | 45.42% |
| 2013-12-31 | 43.19% |
| 2013-09-30 | 44.97% |
| 2013-06-30 | 46.35% |
| 2013-03-31 | 47.02% |
| 2012-12-31 | 47.47% |
| 2012-09-30 | 45.95% |
| 2012-06-30 | 47.78% |
| 2012-03-31 | 47.31% |
| 2011-12-31 | 45.57% |
| 2011-09-30 | 45.02% |
| 2011-06-30 | 47.10% |
| 2011-03-31 | 47.01% |
| 2010-12-31 | 48.70% |
| 2010-09-30 | 47.51% |
| 2010-06-30 | 46.52% |
| 2010-03-31 | 48.60% |
| 2009-12-31 | 47.38% |
| 2009-09-30 | 48.71% |
| 2009-06-30 | 49.54% |
| 2009-03-31 | 49.34% |
| 2008-12-31 | 50.44% |
| 2008-09-30 | 47.20% |
| 2008-06-30 | 46.70% |
| 2008-03-31 | 47.05% |
| 2007-12-31 | 47.15% |
| 2007-09-30 | 47.93% |
| 2007-06-30 | 48.92% |
| 2007-03-31 | 49.29% |
| 2006-12-31 | 48.90% |
| 2006-09-30 | 49.43% |
| 2006-06-30 | 50.82% |
| 2006-03-31 | 51.12% |
| 2005-12-31 | 51.11% |
| 2005-09-30 | 49.51% |
| 2005-06-30 | 31.60% |
| 2005-03-31 | 49.24% |
| 2004-12-31 | 51.77% |
| 2004-09-30 | 49.09% |
| 2004-06-30 | 50.30% |
| 2004-03-31 | 47.92% |
| 2003-12-31 | 48.40% |
| 2003-09-30 | 49.45% |
| 2003-06-30 | 51.08% |
| 2003-03-31 | 50.52% |
| 2002-12-31 | 47.93% |
| 2002-09-30 | 48.57% |
